CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C02004 | BRD-A81879813 | BRD-A81879813 | -- | -- | -- | Details |
C02005 | BRD-A81936046 | BRD-A81936046 | -- | -- | -- | Details |
C02006 | BRD-A82035391 | tolvaptan | AVPR1A; AVPR2 | Vasopressin receptor antagonist | -- | Details |
C02007 | BRD-A82096673 | KU-C103428N | NFE2 | CDC inhibitor; Rho associated kinase inhibitor | -- | Details |
C02008 | BRD-A82156122 | saxagliptin | DPP4 | Dipeptidyl peptidase inhibitor | -- | Details |
C02009 | BRD-A82197375 | BRD-A82197375 | -- | -- | -- | Details |
C02010 | BRD-A82238138 | budesonide | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
C02011 | BRD-A82307304 | atorvastatin | DPP4; HMGCR | HMGCR inhibitor | -- | Details |
C02012 | BRD-A82323890 | BRD-A82323890 | -- | -- | -- | Details |
C02013 | BRD-A82329351 | cycloheximide | RPL3 | Protein synthesis inhibitor | -- | Details |
C02014 | BRD-A82371568 | clofarabine | POLA1; RRM1; RRM2 | Ribonucleoside reductase inhibitor | -- | Details |
C02015 | BRD-A82394575 | BRD-A82394575 | -- | -- | -- | Details |
C02016 | BRD-A82395837 | ginkgolide-b | GLRA1; GLRB; PTAFR | Reducing agent; Immunosuppressant; Protease inhibitor; Peptidase inhibitor; GABA receptor antagonist; Glycine receptor antagonist; Platelet activating factor receptor antagonist | -- | Details |
C02017 | BRD-A82396632 | miconazole | -- | -- | -- | Details |
C02018 | BRD-A82522119 | tibolone | ESR1; AR; PGR | Androgen receptor agonist; Estrogen receptor agonist; Progesterone receptor agonist | -- | Details |
C02019 | BRD-A82590476 | SDZ-NKT-343 | TACR1 | Tachykinin antagonist | -- | Details |
C02020 | BRD-A82628254 | BRD-A82628254 | -- | -- | -- | Details |
C02021 | BRD-A82656074 | naltrindole | OPRD1 | Opioid receptor antagonist | -- | Details |
C02022 | BRD-A82720512 | ML-258 | -- | -- | -- | Details |
C02023 | BRD-A82772293 | mepazine | MALT1 | MALT1 inhibitor | -- | Details |
C02024 | BRD-A82843133 | BRD-A82843133 | -- | -- | -- | Details |
C02025 | BRD-A82892199 | alpha-tocopherol | -- | -- | -- | Details |
C02026 | BRD-A82913781 | BRD-A82913781 | -- | -- | -- | Details |
C02027 | BRD-A82976242 | BRD-A82976242 | -- | -- | -- | Details |
C02028 | BRD-A82976259 | BRD-A82976259 | -- | -- | -- | Details |
C02029 | BRD-A83029242 | prasugrel | P2RY12 | Purinergic receptor antagonist | -- | Details |
C02030 | BRD-A83029311 | butirosin | -- | -- | -- | Details |
C02031 | BRD-A83081521 | finasteride | SRD5A1; SRD5A2 | 5 alpha reductase inhibitor | -- | Details |
C02032 | BRD-A83124583 | EMF-sumo1-39 | -- | -- | -- | Details |
C02033 | BRD-A83237092 | none | ESR1 | Estrogen receptor antagonist | -- | Details |
C02034 | BRD-A83255679 | BRD-A83255679 | GPER1 | Estrogen receptor antagonist | -- | Details |
C02035 | BRD-A83326220 | brazilin | -- | -- | -- | Details |
C02036 | BRD-A83387524 | BRD-A83387524 | -- | -- | -- | Details |
C02037 | BRD-A83402799 | BRD-A83402799 | -- | -- | -- | Details |
C02038 | BRD-A83431637 | resmethrin | -- | -- | -- | Details |
C02039 | BRD-A83650191 | A-61603 | -- | -- | -- | Details |
C02040 | BRD-A83672804 | BRD-A83672804 | -- | -- | -- | Details |
C02041 | BRD-A83695761 | chromanol | -- | -- | -- | Details |
C02042 | BRD-A83706824 | BRD-A83706824 | -- | -- | -- | Details |
C02043 | BRD-A83802330 | BRD-A83802330 | -- | -- | -- | Details |
C02044 | BRD-A83815268 | silibinin | -- | -- | -- | Details |
C02045 | BRD-A83855350 | naltrexone | OPRD1; OPRK1; OPRM1 | Opioid receptor antagonist | -- | Details |
C02046 | BRD-A83859836 | tropisetron | HTR3A | Serotonin receptor antagonist | -- | Details |
C02047 | BRD-A83892713 | rifampicin | NR1I2 | RNA polymerase inhibitor | -- | Details |
C02048 | BRD-A83937277 | mephenytoin | SCN5A | Hydantoin antiepileptic | -- | Details |
C02049 | BRD-A83993876 | BRD-A83993876 | -- | -- | -- | Details |
C02050 | BRD-A84045418 | calpeptin | -- | -- | -- | Details |
C02051 | BRD-A84066268 | BRD-A84066268 | -- | -- | -- | Details |
C02052 | BRD-A84098870 | BRD-A84098870 | -- | -- | -- | Details |
C02053 | BRD-A84102390 | BRD-A84102390 | -- | -- | -- | Details |
C02054 | BRD-A84134924 | pancuronium | -- | -- | -- | Details |
C02055 | BRD-A84174393 | meloxicam | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
C02056 | BRD-A84174873 | baclofen | GABBR1; GABBR2 | GABA receptor agonist | -- | Details |
C02057 | BRD-A84189516 | baccatin-III | -- | -- | baccatin-iii | Details |
C02058 | BRD-A84205515 | estriol | ESR1; ESR2 | Estrogen receptor agonist | -- | Details |
C02059 | BRD-A84228258 | brefeldin-a | -- | -- | -- | Details |
C02060 | BRD-A84238007 | BRD-A84238007 | -- | -- | -- | Details |
C02061 | BRD-A84280790 | BRD-A84280790 | -- | -- | -- | Details |
C02062 | BRD-A84282119 | rimantadine | -- | -- | -- | Details |
C02063 | BRD-A84327315 | calcitriol | VDR | Vitamin D receptor agonist | -- | Details |
C02064 | BRD-A84389091 | L-655708 | GABRA5 | GABA receptor inverse agonist | -- | Details |
C02065 | BRD-A84389633 | BRD-A84389633 | -- | -- | tropanyl-3,5-dimethylbenzoate | Details |
C02066 | BRD-A84423900 | BRD-A84423900 | -- | -- | -- | Details |
C02067 | BRD-A84445767 | BRD-A84445767 | -- | -- | -- | Details |
C02068 | BRD-A84465106 | nisoldipine | CACNA1C; CACNA1D; CACNA1S | Calcium channel blocker | -- | Details |
C02069 | BRD-A84475555 | VU-0402605 | -- | -- | -- | Details |
C02070 | BRD-A84481105 | thioridazine | DRD1; DRD2; HTR2A; HTR2C | Dopamine receptor antagonist | -- | Details |
C02071 | BRD-A84493640 | atovaquone | -- | -- | -- | Details |
C02072 | BRD-A84524317 | BRD-A84524317 | -- | -- | -- | Details |
C02073 | BRD-A84524947 | BRD-A84524947 | -- | -- | -- | Details |
C02074 | BRD-A84575140 | pimobendan | PDE3A | Calcium sensitizer; Phosphodiesterase inhibitor | -- | Details |
C02075 | BRD-A84687895 | nilvadipine | CACNA1C; CACNA1D | Calcium channel blocker | -- | Details |
C02076 | BRD-A84695402 | BRD-A84695402 | -- | -- | -- | Details |
C02077 | BRD-A84702196 | penicillin | -- | -- | -- | Details |
C02078 | BRD-A84764193 | BRD-A84764193 | -- | -- | 1-(1H-imidazol-4-ylsulfonyl)-N-1,2,3,4-tetrahydronaphthalen-1-ylpiperidine-4-carboxamide | Details |
C02079 | BRD-A84810646 | ginsenoside-rd | -- | -- | -- | Details |
C02080 | BRD-A84816049 | BRD-A84816049 | -- | -- | -- | Details |
C02081 | BRD-A84867566 | BRD-A84867566 | -- | -- | -- | Details |
C02082 | BRD-A84909344 | BRD-A84909344 | -- | -- | -- | Details |
C02083 | BRD-A84913188 | BRD-A84913188 | -- | -- | -- | Details |
C02084 | BRD-A84923154 | BRD-A84923154 | -- | -- | -- | Details |
C02085 | BRD-A84941884 | BRD-A84941884 | -- | -- | -- | Details |
C02086 | BRD-A85025557 | NCS-382 | GABBR1; SLC52A2; GABBR2 | GABA receptor antagonist | -- | Details |
C02087 | BRD-A85028244 | BRD-A85028244 | -- | -- | -- | Details |
C02088 | BRD-A85137183 | cefprozil | -- | -- | -- | Details |
C02089 | BRD-A85216385 | BRD-A85216385 | -- | -- | 3-alpha-bis-(4-fluorophenyl)-methoxytropane | Details |
C02090 | BRD-A85231803 | BRD-A85231803 | -- | -- | -- | Details |
C02091 | BRD-A85234536 | BRD-A85234536 | -- | -- | N6-cyclopentyladenosine | Details |
C02092 | BRD-A85280935 | quinpirole | DRD2; DRD3; DRD4 | Dopamine receptor agonist | -- | Details |
C02093 | BRD-A85424553 | thioperamide | HRH3; HRH4 | Histamine receptor antagonist | -- | Details |
C02094 | BRD-A85439007 | idoxuridin | -- | -- | -- | Details |
C02095 | BRD-A85472596 | L-670596 | -- | -- | -- | Details |
C02096 | BRD-A85548292 | piketoprofen | -- | -- | -- | Details |
C02097 | BRD-A85587465 | bemesetron | HTR3A | Serotonin receptor antagonist | -- | Details |
C02098 | BRD-A85648045 | vinblastine | TUBB | Tubulin inhibitor; Microtubule inhibitor | -- | Details |
C02099 | BRD-A85667082 | fulvestrant | ESR1 | Estrogen receptor antagonist | -- | Details |
C02100 | BRD-A85712510 | BRD-A85712510 | -- | -- | -- | Details |
C02101 | BRD-A85739295 | BRD-A85739295 | -- | -- | -- | Details |
C02102 | BRD-A85777636 | dieldrin | -- | -- | -- | Details |
C02103 | BRD-A85860691 | chaetocin | SUV39H1 | Histone lysine methyltransferase inhibitor | -- | Details |